MedTrace Logo

Fecal Microbial Transplantation in Patients With Crohn's Disease

NCT03267238 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2022-02-21

No results posted yet for this study

Summary

Fecal Microbiota Transplantation will be offered to eligible Crohn's disease patient as Investigational New Drug treatment

Conditions

  • Crohn Disease

Interventions

BIOLOGICAL

Fecal Microbial Transplantation

Fecal Microbial Transplantation via will be offered to eligible Crohn's patient

Sponsors & Collaborators

Principal Investigators

  • Ellen Li, MD, PhD · Stony Brook University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-16
Primary Completion
2022-02-15
Completion
2022-02-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03267238 on ClinicalTrials.gov